What does DR. ERIK NOBEN do?

DR. ERIK NOBEN is a general practice in Tongeren-Borgloon. Private Limited, started on 21 May 2010.

What is the address of DR. ERIK NOBEN?

The registered office of DR. ERIK NOBEN is located at Nieuwesteenweg 65, 3840 Tongeren-Borgloon.

Is DR. ERIK NOBEN still active?

Yes. According to the CBE (17 September 2026) DR. ERIK NOBEN is active, legal situation “Normale toestand”, started on 21 May 2010.

Is DR. ERIK NOBEN registered on Peppol?

Yes, DR. ERIK NOBEN is registered on the Peppol network with ID 0208:0826178001.

What is the enterprise number of DR. ERIK NOBEN?

The enterprise number of DR. ERIK NOBEN is BE0826178001.

When was DR. ERIK NOBEN founded?

DR. ERIK NOBEN was founded on 21 May 2010.

Who are the directors of DR. ERIK NOBEN?

According to the 2025 annual accounts, the directors of DR. ERIK NOBEN are: Erik Noben.

Is DR. ERIK NOBEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 May 2010; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. ERIK NOBEN make in 2025?

DR. ERIK NOBEN posted a profit after taxes of € 31,024 in financial year 2025.

What is the revenue of DR. ERIK NOBEN?

As a small company, DR. ERIK NOBEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 88,728.

DR. ERIK NOBEN (Private Limited) - Tongeren-Borgloon

Dossier DR. ERIK NOBEN, printed on 17 September 2026 from databakkes.be/en/0826178001/dr-erik-noben. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. ERIK NOBEN from Tongeren-Borgloon, company number BE0826178001, closed financial year 2025 with a result of € 31,024 after tax. For that financial year DR. ERIK NOBEN recorded a gross margin of € 88,728 and equity of € 164,015. Compared with financial year 2024, the result moved from € 37,919 to € 31,024. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 2, 2026.

What it is worth Healthy

€ 164,015

▼ 36% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 31,024

▼ 18% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 58,173

▲ 83% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 123,472 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 36,730

▼ 32% vs 2024

Of which on lease € 13,281.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 33,154

▼ 4% vs 2024

€ 17,334 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 15,407

▲ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,818

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 106,160 Gross margin 2022: € 106,160 First fiscal year in the series	€ 74,983 Gross margin 2023: € 74,983 ▼ 29% vs 2022 (€ 106,160) Unfavourable step	€ 94,454 Gross margin 2024: € 94,454 ▲ 26% vs 2023 (€ 74,983) Favourable step	€ 88,728 Gross margin 2025: € 88,728 ▼ 6% vs 2024 (€ 94,454) Unfavourable step	▼ 6%
Profit after taxes	€ 60,872 Profit after taxes 2022: € 60,872 First fiscal year in the series	€ 30,829 Profit after taxes 2023: € 30,829 ▼ 49% vs 2022 (€ 60,872) Unfavourable step	€ 37,919 Profit after taxes 2024: € 37,919 ▲ 23% vs 2023 (€ 30,829) Favourable step	€ 31,024 Profit after taxes 2025: € 31,024 ▼ 18% vs 2024 (€ 37,919) Unfavourable step	▼ 18%
Equity	€ 193,715 Equity 2022: € 193,715 First fiscal year in the series	€ 218,544 Equity 2023: € 218,544 ▲ 13% vs 2022 (€ 193,715) Favourable step	€ 256,463 Equity 2024: € 256,463 ▲ 17% vs 2023 (€ 218,544) Favourable step	€ 164,015 Equity 2025: € 164,015 ▼ 36% vs 2024 (€ 256,463) Unfavourable step	▼ 36%
Total debts	€ 65,702 Total debts 2022: € 65,702 First fiscal year in the series	€ 69,384 Total debts 2023: € 69,384 ▲ 6% vs 2022 (€ 65,702) Unfavourable step	€ 46,970 Total debts 2024: € 46,970 ▼ 32% vs 2023 (€ 69,384) Favourable step	€ 172,033 Total debts 2025: € 172,033 ▲ 266% vs 2024 (€ 46,970) Unfavourable step	▲ 266%
Cash	€ 66,360 Cash 2022: € 66,360 First fiscal year in the series	€ 25,197 Cash 2023: € 25,197 ▼ 62% vs 2022 (€ 66,360) Unfavourable step	€ 31,721 Cash 2024: € 31,721 ▲ 26% vs 2023 (€ 25,197) Favourable step	€ 58,173 Cash 2025: € 58,173 ▲ 83% vs 2024 (€ 31,721) Favourable step	▲ 83%
Land & buildings	€ 28,040 Land & buildings 2022: € 28,040 First fiscal year in the series	€ 24,767 Land & buildings 2023: € 24,767 ▼ 12% vs 2022 (€ 28,040) Unchanged	€ 22,693 Land & buildings 2024: € 22,693 ▼ 8% vs 2023 (€ 24,767) Unchanged	€ 19,242 Land & buildings 2025: € 19,242 ▼ 15% vs 2024 (€ 22,693) Unchanged	▼ 15%
Retained profit	€ 181,315 Retained profit 2022: € 181,315 First fiscal year in the series	€ 206,144 Retained profit 2023: € 206,144 ▲ 14% vs 2022 (€ 181,315) Favourable step	€ 244,063 Retained profit 2024: € 244,063 ▲ 18% vs 2023 (€ 206,144) Favourable step	€ 151,615 Retained profit 2025: € 151,615 ▼ 38% vs 2024 (€ 244,063) Unfavourable step	▼ 38%
Dividend	€ 3,210 Dividend 2022: € 3,210 First fiscal year in the series	€ 6,000 Dividend 2023: € 6,000 ▲ 87% vs 2022 (€ 3,210) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 6,000) Unchanged	€ 123,472 Dividend 2025: € 123,472 Unchanged (€ 0) Unchanged
Bank debt	€ 46,150 Bank debt 2022: € 46,150 First fiscal year in the series	€ 49,648 Bank debt 2023: € 49,648 ▲ 8% vs 2022 (€ 46,150) Unfavourable step	€ 34,548 Bank debt 2024: € 34,548 ▼ 30% vs 2023 (€ 49,648) Favourable step	€ 33,154 Bank debt 2025: € 33,154 ▼ 4% vs 2024 (€ 34,548) Favourable step	▼ 4%
Balance sheet total	€ 259,418 Balance sheet total 2022: € 259,418 First fiscal year in the series	€ 287,928 Balance sheet total 2023: € 287,928 ▲ 11% vs 2022 (€ 259,418) Unchanged	€ 303,433 Balance sheet total 2024: € 303,433 ▲ 5% vs 2023 (€ 287,928) Unchanged	€ 336,048 Balance sheet total 2025: € 336,048 ▲ 11% vs 2024 (€ 303,433) Unchanged	▲ 11%

Key figures of DR. ERIK NOBEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to DR. ERIK NOBEN?

What happened at DR. ERIK NOBEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 2, 2026 New annual accounts for financial year 2025: profit of € 31,024 (▼ 18% vs 2024). Source: NBB ↗
May 21, 2010 Start of the company according to the CBE. KBO

In short

From € 60,872 profit in 2022 to € 31,024 profit in 2025.

Paid € 76,488 in corporate taxes since 2022.

Best year ever: 2022, with € 60,872 profit.

Paid out € 132,682 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. ERIK NOBEN? We notify you, reason included.

Follow DR. ERIK NOBEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Erik Noben

DR. ERIK NOBEN

Immo Parel 26.4%

Behind DR. ERIK NOBEN is Erik Noben. It owns 26.4% of Immo Parel itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Erik Noben

Director

Also active at: IMMO PAREL

Establishments

Establishment units

Physical locations of this company

Registered office

Nieuwesteenweg 65

3840 Tongeren-Borgloon

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0826.178.001

VAT number

BE 0826.178.001

Registered office

Nieuwesteenweg 65, 3840 Tongeren-Borgloon

Names & denominations

DR. ERIK NOBEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 May 2010

Peppol

Active · Active since 30 Oct 2025

Activities · NACE

Activiteiten van huisartspraktijken

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. ERIK NOBEN

Financials

What happened to DR. ERIK NOBEN?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions